← Open Payments lookup

JEAN DAVIS: Open Payments

NPI 1801294756 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,157 in 56 payments from 13 companies in 2025. Trend: 2023 $1,714 · 2024 $3,051 · 2025 $1,157

Food & beverage: $1,157
CompanyPaymentsAmount
ABBVIE INC.14$297
Janssen Biotech, Inc.9$182
Gilead Sciences, Inc.7$137
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$94
Madrigal Pharmaceuticals4$91
Organon LLC5$91
Intercept Pharmaceuticals, Inc.4$77
Ipsen Biopharmaceuticals, Inc2$47
Napo Pharmaceuticals Inc2$39
Mirum Pharmaceuticals, Inc.1$34

Products named: TREMFYA, RINVOQ, SKYRIZI, XIFAXAN, REZDIFFRA, HADLIMA, OCALIVA, MAVYRET.

Industry payments across TX — which companies pay providers there.